Down syndrome (DS) iPSCs have been used as an alternative to model AD phenotypes such that DS iPSC-derived neurons express similar AD cytopathies, early amyloid aggregates and overexpressed tau that is hyperphosphorylated and mislocalized into the linear foci in soma and dendrites [96,97]. Here, MAPT is linked to Alzheimer disease.